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Introduction: Increased transmissibility of B.1.1.7 variant of concern 
(VOC) in the UK may explain its rapid emergence and global spread. 
We analysed data from putative household infector - infectee pairs in 
the Virus Watch Community cohort study to assess the serial interval 
of COVID-19 and whether this was affected by emergence of the 
B.1.1.7 variant. 
Methods: The Virus Watch study is an online, prospective, community 
cohort study following up entire households in England and Wales 
during the COVID-19 pandemic. Putative household infector-infectee 
pairs were identified where more than one person in the household 
had a positive swab matched to an illness episode. Data on whether or 
not individual infections were caused by the B.1.1.7 variant were not 
available. We therefore developed a classification system based on the 
percentage of cases estimated to be due to B.1.1.7 in national 
surveillance data for different English regions and study weeks. 
Results: Out of 24,887 illnesses reported, 915 tested positive for SARS-
CoV-2 and 186 likely ‘infector-infectee’ pairs in 186 households 
amongst 372 individuals were identified. The mean COVID-19 serial 
interval was 3.18 (95%CI: 2.55 - 3.81) days. There was no significant 
difference (p=0.267) between the mean serial interval for VOC 
hotspots (mean = 3.64 days, (95%CI: 2.55 – 4.73)) days and non-VOC 
hotspots, (mean = 2.72 days, (95%CI: 1.48 – 3.96)). 
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Conclusions: Our estimates of the average serial interval of COVID-19 
are broadly similar to estimates from previous studies and we find no 
evidence that B.1.1.7 is associated with a change in serial intervals.  
Alternative explanations such as increased viral load, longer period of 
viral shedding or improved receptor binding may instead explain the 
increased transmissibility and rapid spread and should undergo 
further investigation.
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Introduction
The serial interval is defined as “the period of time between 
analogous phases of an infectious illness in successive cases of 
a chain of infection that is spread person to person” (Feinleib 
et al., 2001). Serial interval is often measured as the duration 
between symptom onset of a primary case and symptom onset 
of its secondary cases. This is a key epidemiological measure 
because it can allow investigation of epidemiological links 
between cases, and it is an important parameter in infection 
transmission models used to inform infection control strategies. 
The doubling time of epidemic infections is in part dependent 
on both the serial interval and the R number (the average 
number of secondary infections each infection produces). Dis-
eases with shorter serial intervals but similar R values will have 
shorter doubling times. Mean serial intervals vary widely for 
different respiratory infections and have been estimated at 2.2 
days for influenza A H3N2, 2.8 days for pandemic influenza 
A(H1N1)pdm09, 7.5 days for respiratory syncytial virus, 11.7 
days for measles, 14 days for varicella, 17.7 days smallpox, 
18.0 days for mumps, 18.3 days for rubella and 22.8 days for 
pertussis (Vink et al., 2014).
Published estimates of the serial interval of coronavirus disease 
2019 (COVID-19) are largely from Asian countries prior to 
the emergence of variants of concern (VOC). A meta-analysis 
of serial interval estimates for COVID-19 found mean serial 
intervals ranged from 4.2 to 7.5 days with a pooled mean of 
5.2 (95%CI: 4.9–5.5) (Alene et al., 2021). A more recent 
concerning feature of COVID-19 epidemiology has been the 
emergence of a range of SARS-CoV-2 variants with mutations 
that may increase transmissibility, reduce the protective effect of 
immunity acquired from natural infection or vaccination and/
or increase clinical severity (Alene et al., 2021). These include 
B.1.1.7 (first described in England), 501Y.V2 (first described 
in South Africa) and P.1 (B.1.1.28.1 - first described in Brazil). 
Each of these variants rapidly became dominant in the country 
in which they were first described. For the B.1.1.7 variant, 
increased transmissibility is thought to explain the rapid emer-
gence and global spread. Since either increased R or decreased 
serial interval could potentially explain more rapid emergence 
of B.1.1.7, it is important to understand whether serial interval 
differs. To date, however, there are no published comparisons of 
the serial interval for B.1.1.7 and previously circulating strains. 
We analysed data from putative household infector - infectee 
pairs in the Virus Watch Community cohort study to assess the 
serial interval of COVID-19 and whether this was affected by 
emergence of the B.1.1.7 variant. 
Methods
This study has been approved by the Hampstead NHS Health 
Research Authority Ethics Committee. Ethics approval number 
- 20/HRA/2320. All members of participating households pro-
vided informed consent for themselves and, where relevant, for 
children that they were responsible for. This was electronically 
collected during registration. All necessary patient/participant 
consent has been obtained and the appropriate institutional 
forms have been archived.
The Virus Watch study is an online, prospective, community 
cohort study following up entire households in England and 
Wales during the COVID-19 pandemic. Participants were 
recruited into the Virus Watch study using a range of methods 
including by post, social media, SMS messages or personal-
ised letters with incentives from General Practices. Participants 
were eligible if all household members agreed to take part, 
if they had access to the internet (Wi-Fi, fixed or on a mobile 
phone) and an email address. At least one household mem-
ber had to be able to read English to complete the surveys. 
Participants were not eligible if their household was larger than 
6 people (due to limitations of the online survey infrastruc-
ture). The full study design and methodology has been described 
elsewhere (Hayward et al., 2020). Study data were collected and 
managed using REDCap electronic data capture tools hosted 
at University College London (Harris et al., 2009). Data col-
lection began on 24 June 2020 and is ongoing. As of 11th 
April 2021, 49,149 people across England and Wales have 
joined the study. Participants prospectively complete detailed 
daily symptom diaries recording the presence and severity of 
any symptoms of acute respiratory, gastrointestinal and other 
illnesses. At the end of each week participants are emailed a 
link to complete a weekly online survey where they report any 
symptoms from that previous week as well as the dates and 
outcomes of any COVID-19 swabbing conducted as part of 
NHS Test and Trace, work-based testing schemes, and other 
research studies.
Symptom data were extracted and grouped into illness epi-
sodes using Stata (StataCorp, 2019). The start date of an ill-
ness episode was defined as the first day any symptoms 
were reported, and the end date was the final day of reported 
symptoms. A seven-day washout period where no symptoms 
were reported was used to define the end of one illness episode 
and the start of a new illness episode. Swab results were matched 
to illnesses that were within 14 days of each other. Putative 
household infector-infectee pairs were identified where more 
than one person in the household had a positive swab matched 
to an illness episode. Although negative serial intervals are 
possible, in practice it is not possible to assess the direction of 
transmission between pairs, so it was assumed that the mini-
mum interval was zero days. According to the World Health 
Organization report on SARS-CoV-2 transmission, the estimated 
latest transmission can occur up to nine days after the infec-
tor’s symptom onset & the incubation period for the infectee 
can be up to 14 days (WHO, 2020). Thus, the longest time 
interval between an infector’s and an infectee’s onset of symp-
toms was considered at 23 days. Our analysis conducted using 
R version 4.0.3 (R Core Team, 2020), considered pairs of cases 
with symptom onset occurring between 0 and 23 days apart 
in households as possible transmission pairs (Geismar, 2021). 
Serial interval was calculated as the number of days between 
symptom onset of the pairs of cases. Figure 1 presents a hypo-
thetical household with four confirmed COVID-19 cases and 
their respective symptom onset date. Any case with a symp-
tom onset date within 23 days of a previous case will be paired. 
Where there were multiple potential infectors for the same 
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infectee, these pairs were excluded from the analysis. ‘Person 
#4’ has two potential infectors as her symptom onset date is 
within 23 days of ‘Person #2’ and ‘Person #3’ ‘s symptom 
onset dates. Pairs containing ‘Person #4’ as an infectee will be 
removed since we cannot determine her “true” infector. Thus, we 
only retain the two most likely transmission pairs: ‘Person #1’ 
to ‘Person #2’ and ‘Person #2’ to ‘Person #3’.
Data on whether or not individual infections were caused by 
the B.1.1.7 variant were not available. We therefore developed 
a classification system based on the percentage of cases esti-
mated to be due to B.1.1.7 in national surveillance data for 
different English regions and study weeks. These surveillance 
data utilise a proxy indicator of B.1.1.7 known as Spike-gene 
target failure (SGTF) which can be picked up on most 
polymerase chain reaction (PCR) assays used in English com-
munity testing programmes. Infections in regions and weeks 
when >75% of strains were SGTF were classified as occurring 
in B.1.1.7 “hotspots”. Infections in regions and weeks when 
<25% of strains were SGTF were classified as occurring in 
“non-hotspots”. Infections in regions and weeks when 25% to 
75% of strains were SGTF were classified as “undetermined” 
since no significant threshold was reached. Mean serial interval 
and 95% confidence intervals were compared in hotspot 
and non-hotspot areas using Welch two-sample t-tests.
Results
Out of 24,887 illnesses reported by 14,986 individuals within 
9,991 households between 22/06/2020 and 07/03/2021, 7,304 
were tested for SARS-CoV-2. Amongst the swabbed illnesses, 
915 tested positive for SARS-CoV-2. 287 possible ‘infector-
infectee’ pairs in 194 households amongst 424 individuals were 
identified. Non-unique infectees (infectees with multiple poten-
tial infectors) were then excluded as their infectors could not 
be determined, resulting in 186 likely pairs in 186 households 
amongst 372 individuals between 03/09/2020 and 22/02/2021. 
43 ‘infector-infectee’ pairs were identified in non-hotspot areas 
between 03/09/2020 – 05/12/2020, 69 were in hotspot areas 
between 14/12/2020 – 22/02/2021 and 74 in areas not determined 
between 09/09/2020 – 25/01/2021 (Table 1 and Table 2).
Figure 2 shows the distribution of serial intervals. The dis-
tribution peaks between 0 and 1 day and 90% of all observa-
tions lie between 0 and 8.5 days, with values spanning up to 21 
days. The mean COVID-19 serial interval was 3.18 (95%CI: 
2.55 - 3.81) days and its median was 2 days (Table 2).
Figure 3 compares the distribution of serial intervals for B.1.1.7 
hotspot areas and non-hotspot areas. There was no significant 
difference (p=0.267) between the mean serial interval for VOC 
hotspots (mean = 3.64 days (95%CI: 2.55 – 4.73), median 
= 2 days) days and non-VOC hotspots, (mean = 2.72 days 
(95%CI: 1.48 – 3.96), median = 1 day) (Table 2).
Discussion
Our estimate of the mean serial interval of COVID-19 
(3.18 days (95%CI: 2.55 - 3.81)) is within the range of previ-
ous studies reviewed by Griffin et al. (2020), but slightly lower 
than pooled estimates from meta-analysis of data from inter-
national studies in the first few months of the pandemic (5.2 
(95%CI: 4.9 - 5.5)) (Alene et al., 2021). Differences in popula-
tions, social contact, and timeframes may explain the range of 
estimates reported. The implementation of control measures, 
regular testing, isolation and improved knowledge of SARS-
CoV-2’s transmission since the start of the pandemic, may 
have reduced the potential for an infected person to transmit the 
disease over a long period of time. Multiple studies observed 
and attributed the decrease of the serial interval to increased 
control measures (Bi et al., 2020; Lavezzo et al., 2020; Zhao 
et al., 2020). Ali et al. (2020) modelled the serial interval over 
time accounting for timeliness of cases’ isolation and found 
that “serial intervals are positively associated with isolation 
delay”. Another potential explanation of shorter serial inter-
vals may be due the frequent and close contact among house-
hold members. This could lead to transmissions occurring 
earlier in the course of infection, which would result in shorter 
serial intervals. 
Strengths of the study include the relatively large number of 
pairs compared to most studies, the prospective daily record-
ing of symptoms and weekly reporting of swab test results in a 
large household cohort, and our ability to assess whether a vari-
ant with apparent increases in transmissibility has an altered 
serial interval. Limitations of our analysis include reliance 
on samples taken during the national symptomatic testing pro-
gramme to assess infection, meaning we are likely to have 
missed some infections and household transmission events. 
Pooled asymptomatic proportion of SARS-CoV-2 infections 
is estimated at 23% (95% CI 16%-30%) and we cannot assess 
serial intervals when either case is asymptomatic (Beale et al., 
2020). We can also not assess the possibility of negative serial 
intervals which may arise when transmission occurs prior to 
symptom onset and incubation period is short. Finally, we 
Figure 1. Diagram of a hypothetical SARS-CoV-2 outbreak within a household with individual illnesses start dates.
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n % n % n % n %
Sex (at birth)
Female 179 48.1 71 49.7 41 48.2 67 46.5
Male 170 45.6 68 47.6 42 49.4 60 41.7
Missing 23 6.3 4 2.7 2 2.4 17 11.8
Age (years)
0–15 25 6.7 11 7.7 5 5.9 9 6.2
16–44 114 30.6 45 31.5 26 30.6 43 29.9
45–64 165 44.4 63 44.0 29 34.1 73 50.7
65 + 68 18.3 24 16.8 25 29.4 19 13.2
Region
East Midlands 46 12.4 8 5.6 20 23.5 18 12.5
East of England 56 15.1 36 25.2 2 2.3 18 12.5
London 62 16.7 44 30.7 9 10.6 9 6.2
North East 20 5.4 6 4.2 6 7.1 8 5.6
North West 54 14.5 11 7.7 16 18.8 27 18.7
South East 40 10.7 28 19.6 6 7.1 6 4.2
South West 16 4.3 2 1.4 6 7.1 8 5.6
Wales 10 2.7 0 0.0 0 0.0 10 6.9
West Midlands 18 4.8 6 4.2 4 4.7 8 5.6
Yorkshire and The Humber 28 7.5 2 1.4 16 18.8 10 6.9
Missing 22 5.9 0 0.0 0 0.0 22 15.3
Number of household members
2 214 57.5 71 49.6 55 64.7 88 61.1
3 84 22.6 41 28.7 12 14.1 31 21.5
4 54 14.5 25 17.5 12 14.1 17 11.8
5 16 4.3 2 1.4 6 7.1 8 5.6
6 4 1.1 4 2.8 0 0.0 0 0.0
VOC, variant of concern.











Median serial interval (IQR) 2.0 (0.0 – 4.0) 2.0 (0.0 – 5.0) 1.0 (0.0 – 3.5) 2.0 (0.0 – 3.0)
Mean serial interval 
(95%CI) 3.2 (2.5 – 3.8) 3.6 (2.5 – 4.7) 2.7 (1.5 – 4.0) 3.0 (2.0 – 4.0)
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Figure 2. Serial Interval distribution and mean.
Figure 3. Serial interval density distribution for B.1.1.7 hotspot areas and non-hotspot areas (Mean). VOC, variant of concern.
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do not have individual information on whether strains were 
B.1.1.7 and used a proxy measure of this based on levels of 
SGTF in different areas and times. These limitations reduce 
the likelihood of observing differences between B.1.1.7 other 
wild-type strain types at the time of the study. 
Our analysis does not provide evidence to suggest that changes 
in serial interval explain the rapid emergence of B.1.1.7. Alter-
native explanations such as increased viral load (Kidd et al., 
2021) or improved receptor binding may instead explain the 




We aim to share aggregate data from this project on our 
website and via a “Findings so far” section on our website - 
https://ucl-virus-watch.net/. We will also be sharing individual 
record level data on a research data sharing service such as 
the Office of National Statistics Secure Research Service. In 
sharing the data we will work within the principles set out in 
the UKRI Guidance on best practice in the management of 
research data. Access to use of the data whilst research is being 
conducted will be managed by the Chief Investigators (ACH 
and RWA) in accordance with the principles set out in the 
UKRI guidance on best practice in the management of research 
data. We will put analysis code on publicly available reposi-
tories to enable their reuse. Given the content of our dataset 
(information on infector-infectee pairs per geographic regions) 
for this study, we currently cannot release the data at the indi-
vidual level. Data access requests to data can be made to the 
Virus Watch chief investigators (ACH or RWA) at the following 
email address: viruswatch@ucl.ac.uk.
Extended data
Analysis code available from: https://github.com/UCL-Public-
Health-Data-Science/VirusWatch_COVID_Serial_Interval
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The paper compares the mean serial intervals for COVID-19 in areas with a large incidence of 
variant B.1.1.7, with areas in which the wild variant is dominant, concluding that there is no 
significant difference between the means. 
 
This comparison presents a number of difficulties, most of which are discussed in the paper. These 
difficulties are inherent to estimates of the serial interval distribution, and, although should be 
taken into account, in my opinion, do not invalidate the conclusions, since data about different 
variants was obtained at about the same time, using the same procedure.
The data is restricted to infector-infectee pairs within households, so pairs with people in 
different households are not taken into account. This will probably bias down the observed 
serial intervals since contacts within households tend to be closer. 
 
○
In the introduction, it is mentioned that serial intervals and the doubling time of the 
epidemic are related to the reproduction number - but to be precise, it is the generation 
interval (time between infections) that has this relation. Since the generation interval is 
seldom observable, the serial interval is used as a proxy for it. I believe this should be 
acknowledged in the paper. 
 
○
Due to limitations in the software used, households with more than 6 people were not 
included in the study. It would be good to include in the text how many households are in 
this situation. One limitation of the study is that households with many people would tend 
to lower down the serial interval distribution, since if more people live together, they may 
presumably have closer contacts than in households with less people. However, since the 
same kind of bias was applied to all virus variants, I believe this would not affect the final 
○
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conclusion. 
 
Asymptomatic cases were not included (since the serial interval is not defined for 
asymptomatic cases). This might be a source of bias if one variant has a larger percentage 
of asymptomatic infections than the other.   
 
○
Negative serial intervals were also not considered (the absolute value of the serial interval is 
used instead). Previous studies report a rate of approximately 13% negative serial intervals 
(Griffin et al., 2020). 
 
○
The distribution of serial intervals will depend on NPIs. Despite the fact that the study 
considers cases occurring in different regions at the same time, it might be important to 
check if different regions were not having different sets of restrictions in place (for example, 
in a region under lockdown, people would stay at home most of the time, potentially 
decreasing the within-household serial interval). This potential difference between hotspots 
was not discussed in the paper. 
 
○
Although the mean serial interval is particularly important, the whole distribution affects 
estimates of the reproduction number - so it might be worth comparing the distributions, 
not only their means.
○
 
The study is an important contribution to understanding the observed differences between 
variants, and a worthy contribution to the literature.
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